Birgit Heller

875 total citations
9 papers, 750 citations indexed

About

Birgit Heller is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Birgit Heller has authored 9 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Oncology. Recurrent topics in Birgit Heller's work include Pancreatic function and diabetes (6 papers), Diet, Metabolism, and Disease (4 papers) and PARP inhibition in cancer therapy (3 papers). Birgit Heller is often cited by papers focused on Pancreatic function and diabetes (6 papers), Diet, Metabolism, and Disease (4 papers) and PARP inhibition in cancer therapy (3 papers). Birgit Heller collaborates with scholars based in Germany, Austria and France. Birgit Heller's co-authors include Volker Burkart, Hubert Kolb, Erwin F. Wagner, Zhao‐Qi Wang, Jürgen Radons, Alexander Bürkle, Zdenko Herceg, Laura Stingl, Karin Fehsel and J Radons and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Biochemical and Biophysical Research Communications.

In The Last Decade

Birgit Heller

9 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Heller Germany 6 321 298 162 132 100 9 750
Karen E. Swales United Kingdom 15 310 1.0× 418 1.4× 131 0.8× 95 0.7× 30 0.3× 29 919
D.J. Franks Canada 15 81 0.3× 431 1.4× 108 0.7× 150 1.1× 54 0.5× 28 888
Magali Joffraud Switzerland 14 217 0.7× 496 1.7× 105 0.6× 313 2.4× 227 2.3× 16 1.1k
Michael O’Connor United States 8 146 0.5× 197 0.7× 44 0.3× 71 0.5× 42 0.4× 10 496
Sébastien Jacquet United Kingdom 12 74 0.2× 501 1.7× 212 1.3× 74 0.6× 97 1.0× 14 911
Shefalee K. Bhavsar Germany 19 78 0.2× 513 1.7× 90 0.6× 283 2.1× 66 0.7× 32 883
Ilwola Mattagajasingh United States 9 103 0.3× 562 1.9× 54 0.3× 427 3.2× 80 0.8× 12 1.2k
Franklin Liu United States 13 264 0.8× 748 2.5× 261 1.6× 361 2.7× 36 0.4× 17 1.4k
Z Lojda Czechia 15 148 0.5× 325 1.1× 52 0.3× 146 1.1× 31 0.3× 65 781
Lubing Zhou United States 16 68 0.2× 555 1.9× 160 1.0× 161 1.2× 31 0.3× 33 1.0k

Countries citing papers authored by Birgit Heller

Since Specialization
Citations

This map shows the geographic impact of Birgit Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Heller more than expected).

Fields of papers citing papers by Birgit Heller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Heller. The network helps show where Birgit Heller may publish in the future.

Co-authorship network of co-authors of Birgit Heller

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Heller. A scholar is included among the top collaborators of Birgit Heller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Heller. Birgit Heller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Burkart, Volker, Zhao‐Qi Wang, Jürgen Radons, et al.. (1999). Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nature Medicine. 5(3). 314–319. 313 indexed citations
2.
Heller, Birgit, Alexander Bürkle, J Radons, et al.. (1997). DNA-Damage and NAD+-Depletion are Initial Events in Oxygen Radical Induced Islet Cell Death. Advances in experimental medicine and biology. 426. 329–334. 4 indexed citations
3.
Heller, Birgit, Volker Burkart, E. F. Lampeter, & H.‐A. Kolb. (1996). Antioxidant Therapy for the Prevention of Type I Diabetes. Advances in pharmacology. 38. 629–638. 6 indexed citations
4.
Heller, Birgit, Zhao‐Qi Wang, Erwin F. Wagner, et al.. (1995). Inactivation of the Poly(ADP-ribose) Polymerase Gene Affects Oxygen Radical and Nitric Oxide Toxicity in Islet Cells. Journal of Biological Chemistry. 270(19). 11176–11180. 232 indexed citations
5.
Burkart, Volker, et al.. (1994). Fusidic acid suppresses nitric oxide toxicity in pancreatic islet cells. Biochemical Pharmacology. 48(7). 1379–1385. 7 indexed citations
6.
Radons, J, Birgit Heller, Alexander Bürkle, et al.. (1994). Nitric Oxide Toxicity in Islet Cells Involves Poly(ADP-Ribose) Polymerase Activation and Concomitant NAD+ Depletion. Biochemical and Biophysical Research Communications. 199(3). 1270–1277. 162 indexed citations
7.
Ngezahayo, Anaclet, Birgit Heller, A. Jalowy, et al.. (1994). Nitric oxide toxicity in pancreatic islet cells: role of protein biosynthesis, calcium influx and arachidonic acid metabolism. Biochemical Society Transactions. 22(1). 23–26. 4 indexed citations
8.
Heller, Birgit, et al.. (1988). Depressed in vivo myocardial reactivity to dobutamine in streptozotocin diabetic rats: influence of exercise training. Cardiovascular Research. 22(6). 417–424. 17 indexed citations
9.
Kupke, I, et al.. (1983). Early indicators for the risk of atherogenesis a field test of a new methodology on kindergarten children in Düsseldorf. Atherosclerosis. 48(1). 29–48. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026